Interim analysis
Interim analysis is a statistical procedure that is used in clinical trials to analyze the data before the trial is completed. This is done to determine if the trial should be stopped early due to safety concerns, efficacy, or futility.
Overview[edit]
In clinical research, interim analysis is a planned analysis of data collected from participants before the study is completed. The main purpose of interim analysis is to ensure the safety of the participants and to assess the progress of the trial. It can also be used to determine if the trial should be stopped early due to safety concerns, efficacy, or futility.
Purpose[edit]
The primary purpose of interim analysis is to protect the patient's safety. If the interim analysis shows that the treatment is not effective or is causing harm, the trial can be stopped early to prevent further harm to the participants.
Interim analysis can also be used to determine if the trial is likely to show a significant result if it continues to the end. If the interim analysis shows that the trial is unlikely to show a significant result, the trial can be stopped early to save resources.
Procedure[edit]
Interim analysis is usually performed by a Data Monitoring Committee (DMC) or a similar independent group. The DMC reviews the data collected from the trial and makes recommendations based on their analysis. The DMC can recommend that the trial continue as planned, be modified, or be stopped early.
Limitations[edit]
While interim analysis can provide valuable information, it also has some limitations. One limitation is that it can increase the chance of a Type I error, which is the incorrect rejection of a true null hypothesis. To control for this, statistical methods such as the O'Brien-Fleming method or the Pocock method can be used.
Another limitation is that interim analysis can lead to bias if the results are shared with the trial investigators or participants. To prevent this, the results of the interim analysis are usually kept confidential and are only shared with the DMC.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
